Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
11/2002
11/14/2002WO2002038534A3 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
11/14/2002US20020169326 Fatty acid derivatives
11/14/2002US20020169323 Selective serotonin reuptake inhibitor; antidepressant, anti-Parkinson agent
11/14/2002US20020169192 Peroxisome proliferator activator receptor (PPAR); amino-ethyl- phenyl derivatives
11/14/2002US20020169157 An aromatic or heteroaromatic amino acid derivative, used for treating disorders related to overexpression of protein tyrosine phosphatase-1B
11/14/2002DE10121638A1 Verfahren zur Herstellung von Imidazopyridinen Process for the preparation of imidazopyridines
11/14/2002CA2449187A1 Substituted arylketones
11/14/2002CA2445766A1 Improved process for preparing zolpidem
11/14/2002CA2385809A1 Alkylamide compounds
11/13/2002EP1256576A1 Fused imidazolium derivatives
11/13/2002EP1256569A1 Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
11/13/2002EP1256341A1 Cancer remedy comprising anthranilic acid derivative as active ingredient
11/13/2002EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002CN1379819A Catalytically active recombinant MEMAPSIN and methods of use thereof
11/13/2002CN1379752A Aromatic di-ceto-derivatives use as glucose-6-phosphate translocase inhibitors
11/13/2002CN1379070A Low foaming N,N'-dialkyltartraimine wetting agent
11/13/2002CN1379069A Low foaming N,N'-dialkyl malic imine wetting agent
11/12/2002US6479692 Reacting a keto-carboxy derivative with a substituted aniline to form an amide and treating to form an acylanilide
11/12/2002US6479663 Intermediates useful for the preparation of antihistaminic piperidine derivatives
11/12/2002US6479587 Crosslinkable polyurea polymers
11/12/2002US6479554 Immunotherapeutic agents
11/12/2002US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002US6479548 Substituted stilbenes as glucose uptake enhancers
11/07/2002WO2002088070A1 Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
11/07/2002WO2002088061A1 Novel atisane compound and use thereof
11/07/2002WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002US20020165406 Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
11/07/2002US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165224 Use of y-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism
11/07/2002US20020164760 Catalytically active recombinant memapsin and methods of use thereof
11/06/2002EP1064275B1 Process for producing simvastatin and/or its derivatives
11/05/2002US6476202 5-acylamino-2-arylazo, nitro, or nitroso-4-substituted-phenol compounds and method of using them
11/05/2002US6476076 Vanilloid analogues containing resinferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof
11/05/2002US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476056 Antiinflammatory agents, psychological disorders
11/05/2002US6475477 Radio-opaque polymer biomaterials
10/2002
10/31/2002WO2002085841A2 Substituted catechol derivatives derived from polybasic secondary amino acids, method for production and use thereof
10/31/2002WO2002085836A1 Binaphtol derivative and process for producing the same
10/31/2002WO2002085829A1 Process for production of dimers of aromatic monohydroxyl compounds
10/31/2002WO2002076918A8 NF-λB INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT
10/31/2002WO2002048072A3 Organic reactions with co generating materials
10/31/2002WO2002042412A3 Protease inhibitors and their pharmaceutical uses
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002US20020161050 Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/31/2002US20020161041 Resorcinol derivatives
10/31/2002US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002US20020160987 Novel 4-dedimethylaminotetracycline derivatives
10/30/2002EP1105359B1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions
10/30/2002EP1004573B1 Aryloxyaniline derivatives
10/30/2002EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002CN1377337A Process for phenylacetic acid derivatives
10/30/2002CN1377336A Carboxylic acid derivatives and drugs containing the same
10/30/2002CN1377263A Neuropathy improves containing nitrogenous compounds as the active ingredient
10/29/2002US6472542 Method for alkylating the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin
10/29/2002US6472529 Viricides
10/29/2002US6472435 Antitumor antiproliferation agent formed by amidation of carboxy acid with aromatic amine compound
10/29/2002US6472419 1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents
10/29/2002US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002CA2291068C Method for the preparation of citalopram
10/24/2002WO2002083133A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants
10/24/2002WO2002083120A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
10/24/2002US20020156295 Coordination catalyst containing ligand
10/24/2002US20020156061 Administering to a mammal a matrix metalloproteinase inhibiting amount of derivatives of isophthalic acid, isophthalic acid ester or isothalamide compounds to treat cancer, rheumatic arthritis atherosclerosis and osteoporosis
10/24/2002US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors
10/24/2002US20020155993 Especially those derived from two alpha-amino acids independently selected from the group consisting of glutamic acid, aspartic acid, tyrosine, phenylalanine, and optical isomers thereof.
10/24/2002CA2763637A1 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
10/24/2002CA2443906A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants
10/23/2002EP0717991B1 Neurotropic agent and process for producing it
10/23/2002CN1376143A Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
10/23/2002CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/22/2002US6469210 Excellent fungicidal activity
10/22/2002US6469047 Tyrosine derivatives
10/22/2002US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002US6469005 Propargylether derivatives
10/22/2002US6468502 Paramagnetic macromolecules with higher proton relaxivity; lower dosage and increased signal intensity; detecting vascular diseases; differentiating tissue blood supply levels; distinguishing myocardial infarction from ischemia
10/22/2002US6468487 Nitration or carboxylation catalysts
10/17/2002WO2002081428A1 Benzene compound and salt thereof
10/17/2002WO2001096283A9 Hiv integrase inhibitors
10/17/2002WO2001070664A3 Lipoxin analogs and methods for the treatment of periodontal disease
10/17/2002US20020151750 Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5-carboxamide
10/17/2002US20020151668 Construction of copolymer libraries
10/17/2002US20020151535 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent
10/17/2002US20020150545 Copper sulfat complexes to amino acid
10/16/2002EP1248763A2 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors
10/16/2002CN1374940A O-Anisamide derivatives
10/15/2002US6465455 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/15/2002US6465178 Reagent for covalent attachment of nucleic acids onto the surface of the substrate, comprising a polymer backbone having pendant thermochemically reactive groups; making activated slides for use in microarrays
10/10/2002WO2003084997A1 Probes, systems and methods for drug discovery
10/10/2002WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002WO1998015522A3 Method for preparing trans-4-(4-aminomethylphenyl) cyclohexanol derivatives
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147204 Amide derivative
10/10/2002US20020147191 Antiinflammatory agents, psychological disorders
10/10/2002CA2442654A1 Probes, systems, and methods for drug discovery
10/10/2002CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/09/2002EP1246792A1 Compounds and compositions for delivering active agents
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 157